Health ❯ Healthcare

Weight Management

Obesity Medications Obesity Treatment Weight Loss Weight Loss Drugs Obesity Treatments Weight Loss Medications Weight Loss Treatments Pharmaceuticals Dietary Medications

4 ARTICLES

2w ago

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

The move pauses development of a once‑daily GLP‑1/GIP dual agonist after a 16‑week trial showed A1C reductions, meaningful weight loss, and lower insulin needs.

3 ARTICLES

2w ago

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

5 ARTICLES

last mo.

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

8 ARTICLES

2mo ago

Trial Hints ‘Gut Reset’ May Slow Weight Regain After Stopping GLP‑1 Drugs

11 ARTICLES

2mo ago

Amazon Rolls Out Nationwide GLP-1 Care Program Through One Medical

4 ARTICLES

2mo ago

Anvisa Rejects Three Semaglutide and Liraglutide Drug Filings in Brazil

3 ARTICLES

2mo ago

Doctor Warns GLP‑1 Weight‑Loss Shots Can Reduce Bone Density

4 ARTICLES

2mo ago

GLP-1 Drugs Linked to Lower Addiction Risk and Harm in Large VA Study

5 ARTICLES

3mo ago

Kendra Wilkinson Plans GLP-1 Weight-Loss Shots to Drop a Few Pounds

8 ARTICLES

3mo ago

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

3 ARTICLES

3mo ago

Anvisa Authorizes Multidose Mounjaro Pen for Brazil

3 ARTICLES

3mo ago

Boots and Vitality Launch Exercise‑Linked Discounts of Up to 25% on Weight‑Loss Jabs

4 ARTICLES

3mo ago

FOI Reveals Two Suspected GLP‑1 Drug Deaths in Northern Ireland

18 ARTICLES

3mo ago

Lilly’s Oral GLP-1 Orforglipron Tops Oral Semaglutide in Lancet Phase 3 Diabetes Trial

14 ARTICLES

3mo ago

Government Offers GP Bonuses to Speed NHS Mounjaro Prescribing

4 ARTICLES

3mo ago

UK Regulator Warns Patients Over Fake 15mg Mounjaro Pens Linked to Birmingham Clinic

10 ARTICLES

4mo ago

Private GLP-1 Weight-Loss Use in UK Skews to Middle-Class Women, Analysis Shows

Weight Management

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

Veru Rally Follows Novo Nordisk Deal to Supply Wegovy for Phase 2b Trial

Cigna Drops GLP-1 Weight-Loss Coverage for Its Employees

CHMP Recommends Adding Oral Wegovy Tablets to EU Approval

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

Trial Hints ‘Gut Reset’ May Slow Weight Regain After Stopping GLP‑1 Drugs

Amazon Rolls Out Nationwide GLP-1 Care Program Through One Medical

Anvisa Rejects Three Semaglutide and Liraglutide Drug Filings in Brazil

Doctor Warns GLP‑1 Weight‑Loss Shots Can Reduce Bone Density

Never miss stories about

Weight Management

GLP-1 Drugs Linked to Lower Addiction Risk and Harm in Large VA Study

Kendra Wilkinson Plans GLP-1 Weight-Loss Shots to Drop a Few Pounds

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

Anvisa Authorizes Multidose Mounjaro Pen for Brazil

Boots and Vitality Launch Exercise‑Linked Discounts of Up to 25% on Weight‑Loss Jabs

FOI Reveals Two Suspected GLP‑1 Drug Deaths in Northern Ireland

Lilly’s Oral GLP-1 Orforglipron Tops Oral Semaglutide in Lancet Phase 3 Diabetes Trial

Government Offers GP Bonuses to Speed NHS Mounjaro Prescribing

UK Regulator Warns Patients Over Fake 15mg Mounjaro Pens Linked to Birmingham Clinic

Private GLP-1 Weight-Loss Use in UK Skews to Middle-Class Women, Analysis Shows

Never miss stories about

Weight Management